Sudesh PhD's Colleagues at QED Therapeutics
Sudesh PhD's Contact Details
HQ
650-231-4088
650-231-4088
Location
Company
QED Therapeutics
QED Therapeutics
Sudesh PhD's Company Details
QED Therapeutics, a subsidiary of BridgeBio Pharma, is a biotechnology company focused on precision medicine for FGFR-driven disorders. Our lead candidate is infigratinib, a best-in-class FGFR kinase inhibitor that has shown meaningful clinical activity in chemotherapy-refractory cholangiocarcinoma with FGFR2 fusions. QED is also evaluating infigratinib in preclinical studies for the treatment of achondroplasia. We plan to develop infigratinib in additional FGFR-driven tumor types and rare disorders.
Frequently Asked Questions about Sudesh PhD
Sudesh PhD currently works for QED Therapeutics.
Sudesh PhD's role at QED Therapeutics is Senior Director, Head of Regulatory Affairs CMC.
Sudesh PhD's email address is ***@qedtx.com. To view Sudesh PhD's full email address, please signup to ConnectPlex.
Sudesh PhD works in the Biotechnology industry.
Sudesh PhD's colleagues at QED Therapeutics are Quoc M., Ai Li, Craig Berman, Elena Muslimova, Dan Mulreany, Robyn Leary, Greg Troupe and others.
Sudesh PhD's phone number is 650-231-4088